Physician

Ahmed Elbanna, D.O.

According to 2025 Medicare claims, Ahmed Elbanna, D.O. (NPI: 1003279761) practices gastroenterology in the Deltona-Daytona Beach-Ormond Beach, FL market, with the plurality of this provider's patient population coming from Volusia, FL. This provider's primary affiliated billing organization is GASTRO MD FLORIDA, LLC (NPI: 1821167230; TIN: 74-3189680) and primary practice location at 32763-8427. Elbanna is affiliated with the Mosaic ACO (ACO ID: A5033), participating under the MSSP model.

Elbanna's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 518 traditional Medicare patients, billed 1,687 HCPCS/CPT codes, and received $143,039 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 640 prescription claims across 289 beneficiaries totaling $232,845 in drug costs, led by Linzess (Linaclotide). Open Payments data shows 38 records totaling $1,314. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $9,357 to $232,845. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$72K$143K2019 Medicare payment: $20,594 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $8,770 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $67,647 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $143,039 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
201997229$20,594
20204197$8,770
2021N/RN/RN/R
2022N/RN/RN/R
2023257796$67,647
20245181,687$143,039

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$116K$233K2016 Drug cost: $9,357 (USD; Tot_Drug_Cst)2017 Drug cost: $33,691 (USD; Tot_Drug_Cst)2018 Drug cost: $46,148 (USD; Tot_Drug_Cst)2019 Drug cost: $38,741 (USD; Tot_Drug_Cst)2020 Drug cost: $7,031 (USD; Tot_Drug_Cst)2021 Drug cost: $2,347 (USD; Tot_Drug_Cst)2022 Drug cost: $11,284 (USD; Tot_Drug_Cst)2023 Drug cost: $214,126 (USD; Tot_Drug_Cst)2024 Drug cost: $232,845 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
201639147$9,357
201795409$33,691
201866278$46,148
201952195$38,741
20202984$7,031
20215074$2,347
202254128$11,284
2023151243$214,126
2024289640$232,845

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
45385Removal of polyps or growths of large bowel using an endoscope with mechanical snare118119$203
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes102104$135
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes141278$91
43239Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope137137$74
88305Pathology examination of tissue using a microscope, intermediate complexity117300$25

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LinzessLinaclotide431,800$31,858
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates7078$4,042
OmeprazoleOmeprazole1309,840$1,580
Pantoprazole SodiumPantoprazole Sodium584,394$1,205
FamotidineFamotidine553,836$855

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.38$1,314Phathom Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ahmed Elbanna, D.O.?

Tedicare shows public-source Medicare data for Ahmed Elbanna, D.O. (NPI 1003279761), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmed Elbanna, D.O. have ACO affiliation data?

Ahmed Elbanna, D.O. is shown with ACO affiliation data for Mosaic ACO (MSSP, ACO ID A5033).

What billing organization is linked to Ahmed Elbanna, D.O.?

Ahmed Elbanna, D.O. is linked to GASTRO MD FLORIDA, LLC (billing NPI 1821167230) in the available physician profile data.

Does Ahmed Elbanna, D.O. have Open Payments data?

Ahmed Elbanna, D.O. has 38 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.